Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JTT-705 Dose-Response Study in Type II Hyperlipidaemia
NCT00686010Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- May 2000
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dalcetrapib in hyperlipidemia, sponsored by Japan Tobacco. Started May 2000; status: completed.
02
Drugs
dalcetrapib
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00686010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686010.